ID

22090

Description

Etoposide, Methylprednisolone, High-dose Cytarabine and Oxaliplatin as 2nd Line Therapy for Non-Hodgkin's Lymphoma (NHL); ODM derived from: https://clinicaltrials.gov/show/NCT00336583

Link

https://clinicaltrials.gov/show/NCT00336583

Keywords

Versions (1)
  1. 5/19/17 5/19/17 -
Uploaded on

May 19, 2017

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Non-Hodgkin's Lymphoma NCT00336583

English

Eligibility Non-Hodgkin's Lymphoma NCT00336583

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
previously histologically confirmed aggressive lymphomas, defined according to who classification (except burkitt's lymphoma, lymphoblastic lymphoma)
Description

Aggressive Lymphoma WHO tumor classification | Burkitt Lymphoma | lymphoblastic lymphoma

Data type

boolean

Alias
UMLS CUI [1,1]
C1332225
UMLS CUI [1,2]
C1301142
UMLS CUI [2]
C0006413
UMLS CUI [3]
C0079748
failure to achieve a complete remission with the initial induction chemotherapy, or recurrent disease
Description

Induction Chemotherapy | complete remission failed | Recurrent disease

Data type

boolean

Alias
UMLS CUI [1]
C3179010
UMLS CUI [2,1]
C0677874
UMLS CUI [2,2]
C0231175
UMLS CUI [3]
C0277556
performance status (ecog) ≤3
Description

ECOG performance status

Data type

boolean

Alias
UMLS CUI [1]
C1520224
age ≤ 75
Description

Age

Data type

boolean

Alias
UMLS CUI [1]
C0001779
treated with at least one chop or chop-derived doxorubicin containing regimen
Description

CHOP regimen | Doxorubicin CHOP Derived

Data type

boolean

Alias
UMLS CUI [1]
C0163868
UMLS CUI [2,1]
C0013089
UMLS CUI [2,2]
C0055598
UMLS CUI [2,3]
C1441547
at least one or more uni-dimensionally measurable lesion(s) defined as; ≥2 cm by conventional ct or ≥ 1 cm by spiral ct or skin lesion (photographs should be taken) or measurable lesion by physical examination
Description

Measurable lesion Linear Quantity | Lesion size X-Ray Computed Tomography | Lesion size Spiral Computed Tomography | Skin lesion Photograph | Measurable lesion Physical Examination

Data type

boolean

Alias
UMLS CUI [1,1]
C1513041
UMLS CUI [1,2]
C0205132
UMLS CUI [1,3]
C1265611
UMLS CUI [2,1]
C0449453
UMLS CUI [2,2]
C0040405
UMLS CUI [3,1]
C0449453
UMLS CUI [3,2]
C0860888
UMLS CUI [4,1]
C0037284
UMLS CUI [4,2]
C0441468
UMLS CUI [5,1]
C1513041
UMLS CUI [5,2]
C0031809
adequate organ functions defined as; anc > 1,500/ul, platelet > 75,000/ul, transaminases < 3 x upper normal values; bilirubin < 2 mg%
Description

Organ function | Absolute neutrophil count | Platelet Count measurement | Transaminases | Serum total bilirubin measurement

Data type

boolean

Alias
UMLS CUI [1]
C0678852
UMLS CUI [2]
C0948762
UMLS CUI [3]
C0032181
UMLS CUI [4]
C0002594
UMLS CUI [5]
C1278039
written informed consent approved by institutional review board
Description

Informed Consent

Data type

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
any other malignancies within the past 5 years except skin basal cell ca or cis of cervix
Description

Malignant Neoplasms | Basal cell carcinoma | Carcinoma in situ of uterine cervix

Data type

boolean

Alias
UMLS CUI [1]
C0006826
UMLS CUI [2]
C0007117
UMLS CUI [3]
C0851140
serious co-morbid diseases
Description

Comorbidity Serious

Data type

boolean

Alias
UMLS CUI [1,1]
C0009488
UMLS CUI [1,2]
C0205404
pregnancy or breast-feeding
Description

Pregnancy | Breast Feeding

Data type

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
Back to the top of the page

Similar models

Eligibility Non-Hodgkin's Lymphoma NCT00336583

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Aggressive Lymphoma WHO tumor classification | Burkitt Lymphoma | lymphoblastic lymphoma
Item
previously histologically confirmed aggressive lymphomas, defined according to who classification (except burkitt's lymphoma, lymphoblastic lymphoma)
boolean
C1332225 (UMLS CUI [1,1])
C1301142 (UMLS CUI [1,2])
C0006413 (UMLS CUI [2])
C0079748 (UMLS CUI [3])
Induction Chemotherapy | complete remission failed | Recurrent disease
Item
failure to achieve a complete remission with the initial induction chemotherapy, or recurrent disease
boolean
C3179010 (UMLS CUI [1])
C0677874 (UMLS CUI [2,1])
C0231175 (UMLS CUI [2,2])
C0277556 (UMLS CUI [3])
ECOG performance status
Item
performance status (ecog) ≤3
boolean
C1520224 (UMLS CUI [1])
Age
Item
age ≤ 75
boolean
C0001779 (UMLS CUI [1])
CHOP regimen | Doxorubicin CHOP Derived
Item
treated with at least one chop or chop-derived doxorubicin containing regimen
boolean
C0163868 (UMLS CUI [1])
C0013089 (UMLS CUI [2,1])
C0055598 (UMLS CUI [2,2])
C1441547 (UMLS CUI [2,3])
Measurable lesion Linear Quantity | Lesion size X-Ray Computed Tomography | Lesion size Spiral Computed Tomography | Skin lesion Photograph | Measurable lesion Physical Examination
Item
at least one or more uni-dimensionally measurable lesion(s) defined as; ≥2 cm by conventional ct or ≥ 1 cm by spiral ct or skin lesion (photographs should be taken) or measurable lesion by physical examination
boolean
C1513041 (UMLS CUI [1,1])
C0205132 (UMLS CUI [1,2])
C1265611 (UMLS CUI [1,3])
C0449453 (UMLS CUI [2,1])
C0040405 (UMLS CUI [2,2])
C0449453 (UMLS CUI [3,1])
C0860888 (UMLS CUI [3,2])
C0037284 (UMLS CUI [4,1])
C0441468 (UMLS CUI [4,2])
C1513041 (UMLS CUI [5,1])
C0031809 (UMLS CUI [5,2])
Organ function | Absolute neutrophil count | Platelet Count measurement | Transaminases | Serum total bilirubin measurement
Item
adequate organ functions defined as; anc > 1,500/ul, platelet > 75,000/ul, transaminases < 3 x upper normal values; bilirubin < 2 mg%
boolean
C0678852 (UMLS CUI [1])
C0948762 (UMLS CUI [2])
C0032181 (UMLS CUI [3])
C0002594 (UMLS CUI [4])
C1278039 (UMLS CUI [5])
Informed Consent
Item
written informed consent approved by institutional review board
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Malignant Neoplasms | Basal cell carcinoma | Carcinoma in situ of uterine cervix
Item
any other malignancies within the past 5 years except skin basal cell ca or cis of cervix
boolean
C0006826 (UMLS CUI [1])
C0007117 (UMLS CUI [2])
C0851140 (UMLS CUI [3])
Comorbidity Serious
Item
serious co-morbid diseases
boolean
C0009488 (UMLS CUI [1,1])
C0205404 (UMLS CUI [1,2])
Pregnancy | Breast Feeding
Item
pregnancy or breast-feeding
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial